Compare IMAX & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMAX | ATEC |
|---|---|---|
| Founded | 1967 | 1990 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 1997 | 2006 |
| Metric | IMAX | ATEC |
|---|---|---|
| Price | $40.68 | $12.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $44.44 | $22.36 |
| AVG Volume (30 Days) | 987.0K | ★ 2.3M |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.25 | 15.04 |
| EPS | ★ 0.63 | N/A |
| Revenue | ★ $410,212,000.00 | $101,739,000.00 |
| Revenue This Year | $9.80 | $17.79 |
| Revenue Next Year | $7.11 | $16.43 |
| P/E Ratio | $64.39 | ★ N/A |
| Revenue Growth | ★ 16.47 | N/A |
| 52 Week Low | $20.48 | $8.82 |
| 52 Week High | $43.16 | $23.29 |
| Indicator | IMAX | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 61.80 | 27.69 |
| Support Level | $35.94 | $11.99 |
| Resistance Level | $43.16 | $12.90 |
| Average True Range (ATR) | 1.68 | 0.63 |
| MACD | 0.27 | 0.06 |
| Stochastic Oscillator | 66.11 | 5.61 |
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.